| Product Code: ETC7046794 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Egypt Gene Therapy Products Market Overview |
3.1 Egypt Country Macro Economic Indicators |
3.2 Egypt Gene Therapy Products Market Revenues & Volume, 2021 & 2031F |
3.3 Egypt Gene Therapy Products Market - Industry Life Cycle |
3.4 Egypt Gene Therapy Products Market - Porter's Five Forces |
3.5 Egypt Gene Therapy Products Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Egypt Gene Therapy Products Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Egypt Gene Therapy Products Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Egypt Gene Therapy Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders in Egypt |
4.2.2 Growing awareness and acceptance of gene therapy as a treatment option |
4.2.3 Government initiatives to support research and development in gene therapy |
4.3 Market Restraints |
4.3.1 High cost associated with gene therapy products |
4.3.2 Limited availability of skilled professionals in the field of gene therapy |
4.3.3 Regulatory challenges and approval processes for gene therapy products in Egypt |
5 Egypt Gene Therapy Products Market Trends |
6 Egypt Gene Therapy Products Market, By Types |
6.1 Egypt Gene Therapy Products Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Egypt Gene Therapy Products Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Egypt Gene Therapy Products Market Revenues & Volume, By Yescarta, 2021- 2031F |
6.1.4 Egypt Gene Therapy Products Market Revenues & Volume, By Kymriah, 2021- 2031F |
6.1.5 Egypt Gene Therapy Products Market Revenues & Volume, By Luxturna, 2021- 2031F |
6.1.6 Egypt Gene Therapy Products Market Revenues & Volume, By Strimvelis, 2021- 2031F |
6.1.7 Egypt Gene Therapy Products Market Revenues & Volume, By Gendicine, 2021- 2031F |
6.2 Egypt Gene Therapy Products Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Egypt Gene Therapy Products Market Revenues & Volume, By Oncological Disorders, 2021- 2031F |
6.2.3 Egypt Gene Therapy Products Market Revenues & Volume, By Rare Diseases, 2021- 2031F |
6.2.4 Egypt Gene Therapy Products Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.5 Egypt Gene Therapy Products Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.2.6 Egypt Gene Therapy Products Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.7 Egypt Gene Therapy Products Market Revenues & Volume, By Other Diseases, 2021- 2031F |
6.3 Egypt Gene Therapy Products Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Egypt Gene Therapy Products Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Egypt Gene Therapy Products Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.4 Egypt Gene Therapy Products Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.5 Egypt Gene Therapy Products Market Revenues & Volume, By Others, 2021- 2031F |
7 Egypt Gene Therapy Products Market Import-Export Trade Statistics |
7.1 Egypt Gene Therapy Products Market Export to Major Countries |
7.2 Egypt Gene Therapy Products Market Imports from Major Countries |
8 Egypt Gene Therapy Products Market Key Performance Indicators |
8.1 Number of clinical trials conducted for gene therapy products in Egypt |
8.2 Investment in research and development of gene therapy technologies |
8.3 Number of partnerships and collaborations between local and international biotech companies in the gene therapy sector in Egypt |
9 Egypt Gene Therapy Products Market - Opportunity Assessment |
9.1 Egypt Gene Therapy Products Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Egypt Gene Therapy Products Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Egypt Gene Therapy Products Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Egypt Gene Therapy Products Market - Competitive Landscape |
10.1 Egypt Gene Therapy Products Market Revenue Share, By Companies, 2024 |
10.2 Egypt Gene Therapy Products Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here